Inflammatory bowel disease in children: Current trends

Journal of Gastroenterology

Volumn 45, Issue 7, 2010, Pages 673-682

  Shikhare, Gargi ^a   Kugathasan, Subra ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Children; Crohn's disease; Epidemiology; IBD

Indexed keywords

ADALIMUMAB; AMINOSALICYLIC ACID; AZATHIOPRINE; BACTERIUM ANTIBODY; BUDESONIDE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CERTOLIZUMAB PEGOL; CIPROFLOXACIN; CORTICOSTEROID; CYCLOSPORIN; HLA B27 ANTIGEN; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; METRONIDAZOLE; NATALIZUMAB; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; TACROLIMUS; THALIDOMIDE;

ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ACNE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ANUS FISTULA; APHTHOUS STOMATITIS; ARTHRALGIA; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNITY; BLOOD CELL COUNT; BONE DISEASE; BONE MARROW SUPPRESSION; CAPSULE ENDOSCOPY; CATARACT; CHILD; CHILD HEALTH CARE; CLINICAL FEATURE; COLITIS; COLON RESECTION; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; ECHOGRAPHY; ELEMENTAL DIET; ENTERITIS; ENVIRONMENTAL FACTOR; EPISCLERITIS; ERYTHEMA NODOSUM; FEVER; GASTROINTESTINAL ENDOSCOPY; GENE MUTATION; GROWTH DISORDER; GROWTH RETARDATION; HEADACHE; HEPATITIS; HERITABILITY; HIRSUTISM; HUMAN; ILEOSTOMY; INFECTION; INTESTINE BIOPSY; INTESTINE FLORA; LYMPHOMA; MEDICAL DECISION MAKING; MEDICAL RESEARCH; MOOD DISORDER; MOON FACE; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPENIA; PANCREATITIS; PATHOPHYSIOLOGY; PERIANAL ABSCESS; PREVALENCE; PRIORITY JOURNAL; PROCTITIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSYCHOSIS; PYODERMA GANGRENOSUM; RASH; RECTUM HEMORRHAGE; REMISSION; REVIEW; SIDE EFFECT; SPERMATOZOON COUNT; STRIA; TERATOGENICITY; THROMBOSIS; TUBERCULOSIS; ULCERATIVE COLITIS; UPPER RESPIRATORY TRACT INFECTION; UVEITIS; WEIGHT GAIN; WEIGHT REDUCTION; DRUG DESIGN; INFLAMMATORY BOWEL DISEASES; METHODOLOGY; PROCEDURES;

CAPSULE ENDOSCOPY; CHILD; DRUG DESIGN; HUMANS; INFLAMMATORY BOWEL DISEASES; MAGNETIC RESONANCE IMAGING; RESEARCH; RESEARCH DESIGN;

EID: 77955656994     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0241-5     Document Type: Review

References (71)

1. S Kugathasan RH Judd RG Hoffmann J Heikenen G Telega F Khan, et al. 2003 Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study J Pediatr 143 525 531 10.1067/S0022-3476(03)00444-X 14571234 (Pubitemid 37352514)
2. J Van Limbergen RK Russell HE Drummond MC Aldhous NK Round ER Nimmo, et al. 2008 Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease Gastroenterology 135 1114 1122 10.1053/j.gastro.2008. 06.081 18725221
3. CS Probert V Jayanthi D Pinder AC Wicks JF Mayberry 1992 Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire Gut 33 687 693 10.1136/gut.33.5.687 1:STN:280:DyaK38zgslCqtw%3D%3D 1307684
4. SM Montgomery DL Morris RE Pounder AJ Wakefield 1999 Asian ethnic origin and the risk of inflammatory bowel disease Eur J Gastroenterol Hepatol 11 543 546 10.1097/00042737-199905000-00013 1:STN:280:DC%2BD3c3hs1Sgtw%3D%3D 10755259
5. JK Seo KM Yeon JG Chi 1992 Inflammatory bowel disease in children-clinical, endoscopic, radiologic and histopathologic investigation J Korean Med Sci 7 221 235 1:STN:280:DyaK3s7lvFKltg%3D%3D 1285921
6. Kim BJ, Song SM, Kim KM, Lee YJ, Rhee KW, Jang JY, et al. Characteristics and trends in the incidence of inflammatory bowel disease in Korean children: a single-center experience. Dig Dis Sci. 2009.
7. S Treepongkaruna P Pienvichit P Sornmayura R Pornkul N Wisedopas P Phuapradit 2006 Inflammatory bowel disease in Thai children: presentations and outcomes of treatment Asian Pac J Allergy Immunol 24 73 79 16913191
8. CH Tsai HL Chen YH Ni HY Hsu YM Jeng CJ Chang, et al. 2004 Characteristics and trends in incidence of inflammatory bowel disease in Taiwanese children J Formos Med Assoc 103 685 691 15361941
9. RW Leong JY Lau JJ Sung 2004 The epidemiology and phenotype of Crohn's disease in the Chinese population Inflamm Bowel Dis 10 646 651 10.1097/00054725-200409000-00022 15472528 (Pubitemid 39276475)
10. T Yao T Matsui N Hiwatashi 2000 Crohn's disease in Japan: diagnostic criteria and epidemiology Dis Colon Rectum 43 S85 S93 10.1007/BF02237231 1:STN:280:DC%2BD3crgtl2gsQ%3D%3D 11052483
11. EV Loftus Jr 2004 Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences Gastroenterology 126 1504 1517 10.1053/j.gastro.2004.01.063 15168363 (Pubitemid 38649869)
12. JF Bach 2002 The effect of infections on susceptibility to autoimmune and allergic diseases N Engl J Med 347 911 920 10.1056/NEJMra020100 12239261
13. S Kugathasan D Amre 2006 Inflammatory bowel disease-environmental modification and genetic determinants Pediatr Clin N Am 53 727 749 10.1016/j.pcl.2006.05.009 (Pubitemid 44109714)
14. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007;447:661-78.
15. JP Hugot M Chamaillard H Zouali S Lesage JP Cezard J Belaiche, et al. 2001 Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 599 603 10.1038/35079107 1:CAS:528: DC%2BD3MXksVShtLY%3D 11385576 (Pubitemid 32531408)
16. Y Ogura DK Bonen N Inohara DL Nicolae FF Chen R Ramos, et al. 2001 A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 411 603 606 10.1038/35079114 1:CAS:528:DC%2BD3MXksVShur8%3D 11385577 (Pubitemid 32531409)
17. K Yamazaki D McGovern J Ragoussis M Paolucci H Butler D Jewell, et al. 2005 Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease Hum Mol Genet 14 3499 3506 10.1093/hmg/ddi379 1:CAS:528: DC%2BD2MXhtFymtbvP 16221758 (Pubitemid 41672132)
18. RN Baldassano DA Piccoli 1999 Inflammatory bowel disease in pediatric and adolescent patients Gastroenterol Clin N Am 28 445 458 10.1016/S0889-8553(05) 70064-9 1:STN:280:DyaK1MzgtVyltg%3D%3D (Pubitemid 29306487)
19. Fish D, Kugathasan S. Inflammatory bowel disease. Adolesc Med Clin. 2004;15:67-90, ix.
20. AM Griffiths P Nguyen C Smith JH MacMillan PM Sherman 1993 Growth and clinical course of children with Crohn's disease Gut 34 939 943 10.1136/gut.34.7.939 1:STN:280:DyaK3szksFyrsQ%3D%3D 8344582
21. ME Kanof AM Lake TM Bayless 1988 Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease Gastroenterology 95 1523 1527 1:STN:280:DyaL1M%2FjtFyjtQ%3D%3D 3181677
22. AB Ballinger MO Savage IR Sanderson 2003 Delayed puberty associated with inflammatory bowel disease Pediatr Res 53 205 210 12538776
23. AJ Greenstein HD Janowitz DB Sachar 1976 The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients Medicine (Baltimore) 55 401 412 10.1097/00005792-197609000-00004 1:STN:280:DyaE283ms1Omuw%3D%3D
24. S Danese S Semeraro A Papa I Roberto F Scaldaferri G Fedeli, et al. 2005 Extraintestinal manifestations in inflammatory bowel disease World J Gastroenterol 11 7227 7236 16437620
25. JS Hyams 1994 Extraintestinal manifestations of inflammatory bowel disease in children J Pediatr Gastroenterol Nutr 19 7 21 10.1097/00005176- 199407000-00003 1:STN:280:DyaK2M%2FlsVygsQ%3D%3D 7965480
26. CN Bernstein 2002 Osteoporosis and other complications of inflammatory bowel disease Curr Opin Gastroenterol 18 428 434 10.1097/00001574-200207000- 00006 17033317 (Pubitemid 34665101)
27. FA Jose MB Heyman 2008 Extraintestinal manifestations of inflammatory bowel disease J Pediatr Gastroenterol Nutr 46 124 133 10.1097/MPG. 0b013e318093f4b0 18223370 (Pubitemid 351161117)
28. R Srirajaskanthan M Winter AF Muller 2005 Venous thrombosis in inflammatory bowel disease Eur J Gastroenterol Hepatol 17 697 700 10.1097/00042737-200507000-00001 1:CAS:528:DC%2BD2MXkvFSqt7g%3D 15947544 (Pubitemid 40896413)
29. X Bossuyt 2006 Serologic markers in inflammatory bowel disease Clin Chem 52 171 181 10.1373/clinchem.2005.058560 1:CAS:528:DC%2BD28Xht1Kkur8%3D 16339302 (Pubitemid 43185477)
30. GL Austin NJ Shaheen RS Sandler 2006 Positive and negative predictive values: use of inflammatory bowel disease serologic markers Am J Gastroenterol 101 413 416 10.1111/j.1572-0241.2006.00475.x 16542272 (Pubitemid 43340911)
31. BA Mackalski CN Bernstein 2006 New diagnostic imaging tools for inflammatory bowel disease Gut 55 733 741 10.1136/gut.2005.076612 1:STN:280:DC%2BD283gt1Cktg%3D%3D 16609136
32. K Horsthuis S Bipat RJ Bennink J Stoker 2008 Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies Radiology 247 64 79 10.1148/radiol.2471070611 18372465
33. Nwomeh B. Radiologic evaluation of inflammatory bowel disease. In: Mamula P, editor. Pediatric inflammatory bowel disease. New York: Springer; 2008. p. 193-210.
34. Girardin M. Video capsule endoscopy in pediatric inflammatory bowel disease. In: Mamula P, editor. Pediatric inflammatory bowel disease. New York: Springer; 2008. p. 263-73.
35. Venkatesh K. Endoscopic modalities in pediatric inflammatory bowel disease. In: Mamula P, editor. Pediatric inflammatory bowel disease. New York: Springer; 2008. p. 211-35.
36. V De Matos PA Russo AB Cohen P Mamula RN Baldassano DA Piccoli 2008 Frequency and clinical correlations of granulomas in children with Crohn disease J Pediatr Gastroenterol Nutr 46 392 398 10.1097/MPG.0b013e31812e95e1 18367950 (Pubitemid 351457872)
37. Benchimol EI, Seow CH, Steinhart AH, Griffiths AM. Traditional corticosteroids for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2008:CD006792.
38. Sutherland L, Macdonald JK. Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2006:CD000544.
39. Sutherland L, Macdonald JK. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2006:CD000543.
40. Akobeng AK, Gardener E. Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease. Cochrane Database Syst Rev. 2005:CD003715.
41. J Markowitz K Grancher N Kohn M Lesser F Daum 2000 A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease Gastroenterology 119 895 902 10.1053/gast.2000.18144 1:CAS:528:DC%2BD3cXnvV2hu7Y%3D 11040176
42. J Markowitz J Rosa K Grancher H Aiges F Daum 1990 Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease Gastroenterology 99 1347 1351 1:STN:280:DyaK3M%2FgslSrtw%3D%3D 1976562
43. M Verhave HS Winter RJ Grand 1990 Azathioprine in the treatment of children with inflammatory bowel disease J Pediatr 117 809 814 10.1016/S0022-3476(05)83349-9 1:STN:280:DyaK3M%2FjvVKnsw%3D%3D 2231216
44. MC Dubinsky H Yang PV Hassard EG Seidman LY Kam MT Abreu, et al. 2002 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease Gastroenterology 122 904 915 10.1053/gast.2002.32420 1:CAS:528:DC%2BD38XjtFOmtbc%3D 11910342
45. Alfadhli AA, McDonald JW, Feagan BG. Methotrexate for induction of remission in refractory Crohn's disease. Cochrane Database Syst Rev. 2005:CD003459.
46. Turner D, Grossman AB, Rosh J, Kugathasan S, Gilman AR, Baldassano R, et al. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease. Am J Gastroenterol. 2007;102:2804-12 (quiz 2803, 2813).
47. S Uhlen R Belbouab K Narebski O Goulet J Schmitz JP Cezard, et al. 2006 Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study Inflamm Bowel Dis 12 1053 1057 10.1097/01.mib.0000235103.47280.bb 1:STN:280:DC%2BD28nos1Cqsw%3D%3D 17075346 (Pubitemid 44665475)
48. SB Hanauer BG Feagan GR Lichtenstein LF Mayer S Schreiber JF Colombel, et al. 2002 Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial Lancet 359 1541 1549 10.1016/S0140-6736(02)08512-4 1:CAS:528: DC%2BD38Xkt1Gru70%3D 12047962 (Pubitemid 34621118)
49. P Rutgeerts WJ Sandborn BG Feagan W Reinisch A Olson J Johanns, et al. 2005 Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2462 2476 10.1056/NEJMoa050516 1:CAS:528:DC%2BD2MXhtlShurjE 16339095 (Pubitemid 41770166)
50. Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J, et al. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology. 2007;132:863-73 (quiz 1165-6). (Pubitemid 46454266)
51. BE Sands FH Anderson CN Bernstein WY Chey BG Feagan RN Fedorak, et al. 2004 Infliximab maintenance therapy for fistulizing Crohn's disease N Engl J Med 350 876 885 10.1056/NEJMoa030815 1:CAS:528:DC%2BD2cXhsFyitLo%3D 14985485 (Pubitemid 38252535)
52. JF Colombel WJ Sandborn P Rutgeerts R Enns SB Hanauer R Panaccione, et al. 2007 Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial Gastroenterology 132 52 65 10.1053/j.gastro.2006.11.041 1:CAS:528:DC%2BD2sXit1aqsLw%3D 17241859 (Pubitemid 46108762)
53. MJ Wyneski A Green M Kay R Wyllie L Mahajan 2008 Safety and efficacy of adalimumab in pediatric patients with Crohn disease J Pediatr Gastroenterol Nutr 47 19 25 10.1097/MPG.0b013e318174e886 1:CAS:528:DC%2BD1cXot1ylsL8%3D 18607264
54. WJ Sandborn SB Hanauer P Rutgeerts RN Fedorak M Lukas DG MacIntosh, et al. 2007 Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial Gut 56 1232 1239 10.1136/gut.2006.106781 1:CAS:528: DC%2BD2sXhtVKgsbnE 17299059 (Pubitemid 47300424)
55. WJ Sandborn BG Feagan S Stoinov PJ Honiball P Rutgeerts D Mason, et al. 2007 S. Certolizumab pegol for the treatment of Crohn's disease N Engl J Med 357 228 238 10.1056/NEJMoa067594 1:CAS:528:DC%2BD2sXotVaqurY%3D 17634458 (Pubitemid 47080387)
56. S Schreiber M Khaliq-Kareemi IC Lawrance OO Thomsen SB Hanauer, et al. 2007 Maintenance therapy with certolizumab pegol for Crohn's disease N Engl J Med 357 239 250 10.1056/NEJMoa062897 1:CAS:528:DC%2BD2sXotVejs7g%3D 17634459 (Pubitemid 47080388)
57. WJ Sandborn JF Colombel R Enns BG Feagan SB Hanauer IC Lawrance, et al. 2005 Natalizumab induction and maintenance therapy for Crohn's disease N Engl J Med 353 1912 1925 10.1056/NEJMoa043335 1:CAS:528:DC%2BD2MXhtF2rsbzF 16267322 (Pubitemid 41565956)
58. SR Targan BG Feagan RN Fedorak BA Lashner R Panaccione DH Present, et al. 2007 Natalizumab for the treatment of active Crohn's disease: results of the ENCORE trial Gastroenterology 132 1672 1683 10.1053/j.gastro.2007.03.024 1:CAS:528:DC%2BD2sXmsVymsrc%3D 17484865 (Pubitemid 46695722)
59. Jacobstein D. Antibiotic therapy. In: Mamula P, editor. Pediatric inflammatory bowel disease. New York: Springer; 2008. p. 329-36.
60. LJ Brandt LH Bernstein SJ Boley MS Frank 1982 Metronidazole therapy for perineal Crohn's disease: a follow-up study Gastroenterology 83 383 387 1:STN:280:DyaL383htFKnsg%3D%3D 7084615
61. Shibolet O, Regushevskaya E, Brezis M, Soares-Weiser K. Cyclosporine A for induction of remission in severe ulcerative colitis. Cochrane Database Syst Rev. 2005:CD004277.
62. McDonald JW, Feagan BG, Jewell D, Brynskov J, Stange EF, Macdonald JK. Cyclosporine for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2005:CD000297.
63. Srinivasan R, Akobeng AK. Thalidomide and thalidomide analogues for induction of remission in Crohn's disease. Cochrane Database Syst Rev. 2009:CD007350.
64. Mallon P, McKay D, Kirk S, Gardiner K. Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2007:CD005573.
65. Rolfe VE, Fortun PJ, Hawkey CJ, Bath-Hextall F. Probiotics for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2006:CD004826.
66. Akobeng AK, Thomas AG. Enteral nutrition for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2007:CD005984.
67. RE Kleinman RN Baldassano A Caplan AM Griffiths MB Heyman RM Issenman, et al. 2004 Nutrition support for pediatric patients with inflammatory bowel disease: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition J Pediatr Gastroenterol Nutr 39 15 27 10.1097/00005176-200407000-00005 15187775
68. von Allmen D. Surgical management of Crohn's disease. In: Mamula P, editor. Pediatric inflammatory bowel disease. New York: Springer; 2008. p. 455-68.
69. Mattei P. Surgical treatment of ulcerative colitis. In: Mamula P, editor. Pediatric inflammatory bowel disease. New York: Springer; 2008. p. 469-83.
70. B Shen VW Fazio FH Remzi BA Lashner 2005 Clinical approach to diseases of ileal pouch-anal anastomosis Am J Gastroenterol 100 2796 2807 10.1111/j.1572-0241.2005.00278.x 16393238
71. JA Eaden, et al. 2000 Colorectal cancer complicating ulcerative colitis: a review Am J Gastroenterol 95 2710 2719 10.1111/j.1572-0241.2000.02297.x 1:STN:280:DC%2BD3crgt1yqtA%3D%3D 11051339